Filing Details

Accession Number:
0001070081-19-000009
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-09 17:09:30
Reporting Period:
2019-01-07
Accepted Time:
2019-01-09 17:09:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578962 Walter Stuart Peltz C/O Ptc Therapeutics, Inc.
100 Corporate Court
South Plainfield NJ 07080
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-01-07 1,764 $34.75 24,882 No 4 S Direct
Common Stock Disposition 2019-01-07 339 $34.75 17,947 No 4 S Indirect By Spouse
Common Stock Disposition 2019-01-07 409 $34.75 17,538 No 4 S Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect By Spouse
No 4 S Indirect By Spouse
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right To Buy) $451.20 2019-05-15 41 41 Indirect
Common Stock Stock Option (Right To Buy) $1,149.60 2020-02-02 37 37 Indirect
Common Stock Stock Option (Right To Buy) $490.80 2021-04-27 58 58 Indirect
Common Stock Stock Option (Right To Buy) $218.40 2022-01-10 38 38 Indirect
Common Stock Stock Option (Right To Buy) $10.85 2023-05-15 3,900 3,900 Indirect
Common Stock Stock Option (Right To Buy) $27.05 2024-01-28 4,900 4,900 Indirect
Common Stock Stock Option (Right To Buy) $51.00 2025-01-02 10,880 10,880 Indirect
Common Stock Stock Option (Right To Buy) $30.86 2026-01-03 11,000 11,000 Indirect
Common Stock Stock Option (Right To Buy) $12.64 2026-11-16 2,000 2,000 Indirect
Common Stock Stock Option (Right To Buy) $11.23 2027-01-02 12,600 12,600 Indirect
Common Stock Stock Option (Right To Buy) $18.01 2028-01-02 30,625 30,625 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2019-05-15 41 41 Indirect
2020-02-02 37 37 Indirect
2021-04-27 58 58 Indirect
2022-01-10 38 38 Indirect
2023-05-15 3,900 3,900 Indirect
2024-01-28 4,900 4,900 Indirect
2025-01-02 10,880 10,880 Indirect
2026-01-03 11,000 11,000 Indirect
2026-11-16 2,000 2,000 Indirect
2027-01-02 12,600 12,600 Indirect
2028-01-02 30,625 30,625 Indirect
Footnotes
  1. Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 5,400 shares of restricted stock from a January 3, 2017 grant of 21,600 shares of restricted stock.
  2. Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 975 RSUs from a January 3, 2017 grant of 3,900 RSUs.
  3. Includes: 1) 1,950 unvested RSUs from an award of 3,900 RSUs granted on January 3, 2017, which vests in four equal annual installments over four years, commencing on January 3, 2018; and 2) 5,250 shares of restricted stock granted on January 3, 2018, which vest in four equal annual installments over four years, commencing on January 3, 2019.
  4. The reporting person acquired beneficial ownership of these securities upon his marriage to the owner of the securities in 2018.
  5. Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,312 shares of restricted stock from a January 3, 2018 grant of 5,250 shares of restricted stock.
  6. Currently exercisable.
  7. This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
  8. This option was granted on November 17, 2016 and vests over four years, with 25% of the shares underlying the option vesting on November 17, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on February 17, 2018.
  9. This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
  10. This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.